Oxaliplatin and Cetuximab in First-line Treatment of Metastatic Colorectal Cancer (mCRC)
Clinical trial NCT00125034 · COMPLETED
Trial details
- NCT number
- NCT00125034
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Primary completion
- 2007-03-01
- Enrollment
- 344
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.